0001225208-21-012913.txt : 20211005
0001225208-21-012913.hdr.sgml : 20211005
20211005163200
ACCESSION NUMBER: 0001225208-21-012913
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211004
FILED AS OF DATE: 20211005
DATE AS OF CHANGE: 20211005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mahoney Michael F
CENTRAL INDEX KEY: 0001533022
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 211307125
MAIL ADDRESS:
STREET 1: BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2021-10-04
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001533022
Mahoney Michael F
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
1
Chairman, President & CEO
Common Stock
2021-10-04
4
M
0
134988.0000
6.2800
A
2216810.0000
D
Common Stock
2021-10-04
4
M
0
66054.0000
7.3900
A
2282864.0000
D
Common Stock
2021-10-04
4
S
0
97838.0000
42.4284
D
2185026.0000
D
Common Stock
2021-10-04
4
S
0
103204.0000
43.3891
D
2081822.0000
D
Stock Option (Right to Buy)
6.2800
2021-10-04
4
M
0
134988.0000
0.0000
D
2022-02-27
Common Stock
134988.0000
134988.0000
D
Stock Option (Right to Buy)
7.3900
2021-10-04
4
M
0
66054.0000
0.0000
D
2023-02-28
Common Stock
66054.0000
396322.0000
D
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.02 to $43.01, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.02 to $43.68, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.
/s/ Vance R. Brown, Attorney-in-fact
2021-10-05